$226.29 Million in Sales Expected for Cross Country Healthcare, Inc. (CCRN) This Quarter

Brokerages expect Cross Country Healthcare, Inc. (NASDAQ:CCRN) to report $226.29 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cross Country Healthcare’s earnings, with estimates ranging from $226.02 million to $226.56 million. Cross Country Healthcare posted sales of $222.52 million during the same quarter last year, which suggests a positive year-over-year growth rate of 1.7%. The firm is scheduled to announce its next quarterly earnings results on Wednesday, March 7th.

According to Zacks, analysts expect that Cross Country Healthcare will report full year sales of $226.29 million for the current year, with estimates ranging from $871.39 million to $871.94 million. For the next fiscal year, analysts forecast that the business will report sales of $940.37 million per share, with estimates ranging from $940.11 million to $940.64 million. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Cross Country Healthcare.

Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Wednesday, November 1st. The business services provider reported $0.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.05. Cross Country Healthcare had a net margin of 0.19% and a return on equity of 11.69%. The company had revenue of $228.50 million for the quarter, compared to analysts’ expectations of $228.97 million. During the same period last year, the firm earned $0.24 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis.

Several brokerages have recently commented on CCRN. Credit Suisse Group started coverage on shares of Cross Country Healthcare in a report on Tuesday, November 7th. They set a “neutral” rating and a $13.00 target price on the stock. TheStreet cut shares of Cross Country Healthcare from a “b-” rating to a “c+” rating in a research note on Friday, November 3rd. BMO Capital Markets decreased their price objective on shares of Cross Country Healthcare from $15.00 to $14.00 and set an “outperform” rating on the stock in a research note on Monday, November 6th. Cantor Fitzgerald reissued a “buy” rating and issued a $18.00 price objective on shares of Cross Country Healthcare in a research note on Wednesday, November 1st. Finally, Zacks Investment Research cut shares of Cross Country Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, October 9th. Two analysts have rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. Cross Country Healthcare presently has an average rating of “Hold” and a consensus target price of $15.31.

In other Cross Country Healthcare news, General Counsel Susan E. Ball sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $14.19, for a total value of $354,750.00. Following the sale, the general counsel now owns 126,921 shares in the company, valued at $1,801,008.99. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thomas C. Dircks bought 10,000 shares of the business’s stock in a transaction on Monday, November 6th. The stock was bought at an average price of $11.77 per share, for a total transaction of $117,700.00. Following the transaction, the director now directly owns 104,571 shares of the company’s stock, valued at $1,230,800.67. The disclosure for this purchase can be found here. Company insiders own 3.90% of the company’s stock.

A number of institutional investors have recently modified their holdings of CCRN. BNP Paribas Arbitrage SA boosted its position in Cross Country Healthcare by 57.7% in the second quarter. BNP Paribas Arbitrage SA now owns 9,998 shares of the business services provider’s stock valued at $129,000 after buying an additional 3,660 shares in the last quarter. FDx Advisors Inc. acquired a new stake in Cross Country Healthcare in the third quarter valued at approximately $146,000. Strs Ohio boosted its position in Cross Country Healthcare by 69.5% in the third quarter. Strs Ohio now owns 16,100 shares of the business services provider’s stock valued at $229,000 after buying an additional 6,600 shares in the last quarter. Voya Investment Management LLC boosted its position in Cross Country Healthcare by 16.9% in the second quarter. Voya Investment Management LLC now owns 18,329 shares of the business services provider’s stock valued at $237,000 after buying an additional 2,646 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. acquired a new stake in Cross Country Healthcare in the second quarter valued at approximately $246,000. Hedge funds and other institutional investors own 92.13% of the company’s stock.

Shares of Cross Country Healthcare (NASDAQ:CCRN) traded down $0.03 on Wednesday, hitting $14.18. 318,340 shares of the stock traded hands, compared to its average volume of 219,861. Cross Country Healthcare has a 12 month low of $11.07 and a 12 month high of $16.38. The company has a market capitalization of $518.39, a PE ratio of 22.20, a PEG ratio of 1.26 and a beta of 0.73. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.14 and a quick ratio of 2.14.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://weekherald.com/2017/12/09/226-29-million-in-sales-expected-for-cross-country-healthcare-inc-ccrn-this-quarter.html.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply